A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults

A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults

NCT04956575 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old

NCT01236040 ·Status: COMPLETED ·Phase: PHASE1

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old

NCT05375838 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults

NCT05333289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age

NCT06097273 ·Status: COMPLETED ·Phase: PHASE3

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

NCT06382311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults

NCT05606965 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above

NCT00319098 ·Status: COMPLETED ·Phase: PHASE3

A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy Adults

NCT05827926 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older

NCT06907511 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

NCT05827978 ·Status: COMPLETED ·Phase: PHASE3

A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza

NCT06179446 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults

NCT05868382 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

NCT05426174 ·Status: COMPLETED ·Phase: PHASE1

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

NCT05827068 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older

NCT07121192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

NCT00309647 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Immunogenicity of Two Doses of Adjuvanted Monovalent Influenza Vaccine Administered to Healthy Adult and Elderly Subjects

NCT00841763 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older

NCT05540522 ·Status: COMPLETED ·Phase: PHASE3

Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying MRNA Influenza Vaccine in Healthy Adults

NCT06028347 ·Status: COMPLETED ·Phase: PHASE1

A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza

NCT05227001 ·Status: COMPLETED ·Phase: PHASE1

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

NCT06602024 ·Status: COMPLETED ·Phase: PHASE3

A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults

NCT05397119 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 Years

NCT00309634 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

NCT00125944 ·Status: COMPLETED ·Phase: PHASE3